The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...

As blockbuster GLP-1 injectables like Mounjaro, Wegovy and Ozempic gain traction in India, doctors stress that careful ...

Just before the end of 2025, an oral version of a GLP-1 drug specifically used for weight management moved much closer to reality. On December 22, the U.S. Food and Drug Administration (FDA) approved ...

Randomised trial data show GLP 1 receptor agonists are associated with increased risk of gallbladder and biliary disease, ...

Fox News senior medical analyst Dr. Marc Siegel joins 'America's Newsroom' to discuss the approval of a GLP-1 pill for weight ...

Novo Nordisk plans to quickly launch the pill form of Wegovy but is expected to soon face competition from Eli Lilly.

The next transformative phase of weight-loss medication is upon us, with the US Food and Drug Administration (FDA) approving ...

Indian pharma major Lupin Limited announced that it has entered into an exclusive license, supply and distribution agreement ...

People who switched to the experimental daily GLP-1 pill orforglipron were able to maintain their weight loss after stopping ...

Port Edwards, Wis. (WSAW) - A Port Edwards man is awaiting a life or death heart transplant. The only reason he’s even able to wait for one, is because of GLP-1 medication. Doctors said if he wanted a ...

In 2025, that meant it was impossible for me to scroll through my feed without being visually assaulted by ingratiating ...